Physiological stress increases renal injury in eNOS-knockout mice

Hypertension Research

Volumn 35, Issue 3, 2012, Pages 318-324

  Pointer, Mildred A ^a   Daumerie, Geraldine ^b   Bridges, Lakessha ^a   Yancey, Sadiqa ^a   Howard, Kelly ^a   Davis, Wendell ^c   Huang, Paul ^d   Loscalzo, Joseph ^e  

^a NORTH CAROLINA CENTRAL UNIVERSITY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BIOGEN   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

kidney injury; salt; stress

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE;

AFRICAN AMERICAN; ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; ENVIRONMENTAL FACTOR; EXHAUSTION; HYPERTENSION; KIDNEY FIBROSIS; KIDNEY INJURY; KIDNEY TUBULE DAMAGE; KIDNEY VEIN THROMBOSIS; KNOCKOUT MOUSE; MOUSE; NEPHROSCLEROSIS; NONHUMAN; PERSONAL EXPERIENCE; PHYSIOLOGICAL STRESS; RUNNING; SALT INTAKE; SYSTOLIC BLOOD PRESSURE; WALKING; WILD TYPE;

ANIMALS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; HYPERTENSION; KIDNEY; KIDNEY DISEASES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE TYPE III; PHYSICAL CONDITIONING, ANIMAL; SODIUM CHLORIDE, DIETARY; STRESS, PHYSIOLOGICAL;

EID: 84857950102     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2011.185     Document Type: Article

References (54)

1. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney. US Renal Data System Atlas of End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney: Bethesda, MD, 2005.
2. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney. US Renal Data System Atlas of End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney: Bethesda, MD, 2006.
3. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney National Institutes of Health, National Institute of Diabetes and Digestive and Kidney: Bethesda, MD, 2009; II.
4. Xiao S, Wagner L, Schmidt RJ, Baylis C. Circulating endothelial nitric oxide synthase inhibitory factor in some patients with chronic renal disease. Kidney Int 2001; 59: 1466-1472. (Pubitemid 32281236)
5. Schmidt RJ, Latos DL. Chronic kidney disease: the new epidemic and its impact on west virginia. W V Med J 2009; 105: 12-16, 18.
6. Sheps SG. Overview of JNC VI: new directions in the management of hypertension and cardiovascular risk. Am J Hypertens 1999; 12: 65S-72S. (Pubitemid 29416785)
7. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Stamler J. End-stage renal disease in African-American and white men. 16-year MRFIT findings. JAMA 1997; 277: 1293-1298. (Pubitemid 27194353)
8. Bruce MA, Beech BM, Crook ED, Sims M, Wyatt SB, Flessner MF, Taylor HA, Williams DR, Akylbekova EL, Ikizler TA. Association of socioeconomic status and CKD among African Americans: The Jackson Heart Study. Am J Kidney Dis 2010; 55: 1001-1008.
9. Bruce MA, Beech BM, Sims M, Brown TN, Wyatt SB, Taylor HA, Williams DR, Crook E. Social environmental stressors, psychological factors, and kidney disease. J Investig Med 2009; 57: 583-589.
10. Crews DC, Charles RF, Evans MK, Zonderman AB, Powe NR. Poverty, race, and CKD in a racially and socioeconomically diverse urban population. Am J Kidney Dis 2010; 55: 992-1000.
11. Daumerie G, Bridges L, Yancey S, Davis W, Huang P, Loscalzo J, Pointer MA. The effect of salt on renal damage in eNOS-deficient mice. Hypertens Res 2010; 33: 170-176.
12. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995; 377: 239-242.
13. Shesely EG, Maeda N, Kim HS, Desai KM, Krege JH, Laubach VE, Sherman PA, Sessa WC, Smithies O. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci USA 1996; 93: 13176-13181. (Pubitemid 26382789)
14. Kojda G, Cheng YC, Burchfield J, Harrison DG. Dysfunctional regulation of endothelial nitric oxide synthase (eNOS) expression in response to exercise in mice lacking one enos gene. Circulation 2001; 103: 2839-2844. (Pubitemid 32550074)
15. Patil RD, DiCarlo SE, Collins HL. Acute exercise enhances nitric oxide modulation of vascular response to phenylephrine. Am J Physiol 1993; 265: H1184-H1188.
16. Pointer MA, Livingston JN, Yancey S, McClelland MK, Bukoski RD. Psychosocial factors contribute to resting blood pressure in African Americans. Ethn Dis 2008; 18: 289-293.
17. Clark R, Anderson NB. Efficacy of racism-specific coping styles as predictors of cardiovascular functioning. Ethn Dis 2001; 11: 286-295. (Pubitemid 33584136)
18. Steffen PR, McNeilly M, Anderson N, Sherwood A. Effects of perceived racism and anger inhibition on ambulatory blood pressure in African Americans. Psychosom Med 2003; 65: 746-750. (Pubitemid 37163378)
19. Knudsen KD, Dahl LK, Thompson K, Iwai J, Heine M, Leitl G. Effects of chronic excess salt ingestion. Inheritance of hypertension in the rat. J Exp Med 1970; 132: 976-1000.
20. Gasperin D, Netuveli G, Dias-da-Costa JS, Pattussi MP. Effect of psychological stress on blood pressure increase: A meta-analysis of cohort studies. Cad Saude Publica 2009; 25: 715-726.
21. Brown DJ. Everyday life for black American adults: stress, emotions, and blood pressure. West J Nurs Res 2004; 26: 499-514. (Pubitemid 39090833)
22. Dressler WW. Hypertension in the African American community: social, cultural, and psychological factors. Semin Nephrol 1996; 16: 71-82. (Pubitemid 26084182)
23. Kalinowski L, Dobrucki IT, Malinski T. Race-specific differences in endothelial function: Predisposition of African Americans to vascular diseases. Circulation 2004; 109: 2511-2517. (Pubitemid 38720549)
24. Obialo CI, Hewan-Lowe K. Rapid progression to end-stage renal disease in young hypertensive African Americans with proteinuria. J Natl Med Assoc 1998; 90: 649-655. (Pubitemid 128454262)
25. Pat B, Hughson MD, Nicol JL, Hoy WE, Gobe GC. A comparison of pathomolecular markers of fibrosis and morphology in kidney from autopsies of African Americans and whites. Virchows Arch 2007; 450: 41-50. (Pubitemid 46360748)
26. Marcantoni C, Ma LJ, Federspiel C, Fogo AB. Hypertensive nephrosclerosis in African Americans versus caucasians. Kidney Int 2002; 62: 172-180. (Pubitemid 34754060)
27. Dilaveris PE, Zervopoulos GA, Michaelides AP, Sideris SK, Psomadaki ZD, Gialafos EJ, Gialafos JE, Toutouzas PK. Ischemia-induced reflex sympathoexcitation during the recovery period after maximal treadmill exercise testing. Clin Cardiol 1998; 21: 585-590. (Pubitemid 28363774)
28. Sen N, Tavil Y, Erdamar H, Yazici HU, Cakir E, Akgul EO, Bilgi C, Erbil MK, Poyraz F, Okyay K, Turfan M, Cemri M. Nebivolol therapy improves endothelial function and increases exercise tolerance in patients with cardiac syndrome x. Anadolu Kardiyol Derg 2009; 9: 371-379.
29. Luscher TF. Endogenous and exogenous nitrates and their role in myocardial ischaemia. Br J Clin Pharmacol 1992; 34: 29S-35S.
30. Kaufmann PA, Mandinov L, Seiler C, Hess OM. Impact of exercise-induced coronary vasomotion on anti-ischemic therapy. Coron Artery Dis 2000; 11: 363-369. (Pubitemid 30410235)
31. Mark AL, Victor RG, Nerhed C, Wallin BG. Microneurographic studies of the mechanisms of sympathetic nerve responses to static exercise in humans. Circ Res 1985; 57: 461-469. (Pubitemid 16217989)
32. Fernando P, Bonen A, Hoffman-Goetz L. Predicting submaximal oxygen consumption during treadmill running in mice. Can J Physiol Pharmacol 1993; 71: 854-857. (Pubitemid 24053565)
33. Fewell JG, Osinska H, Klevitsky R, Ng W, Sfyris G, Bahrehmand F, Robbins J. A treadmill exercise regimen for identifying cardiovascular phenotypes in transgenic mice. Am J Physiol 1997; 273: H1595-H1605.
34. Hambrecht R, Adams V, Erbs S, Linke A, Krankel N, Shu Y, Baither Y, Gielen S, Thiele H, Gummert JF, Mohr FW, Schuler G. Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase. Circulation 2003; 107: 3152-3158. (Pubitemid 36793084)
35. Jastrzebski M, Czarnecka D, Rajzer M, Kawecka-Jaszcz K. Increased levels of inflammatory markers in hypertensives with target organ damage. Kardiol Pol 2006; 64: 802-809; discussion 810-801. (Pubitemid 44510424)
36. Karpha M, Lip GV. The pathophysiology of target organ damage in hypertension. Minerva Cardioangiol 2006; 54: 417-429. (Pubitemid 44689838)
37. Ritz E. Hypertension and kidney disease. Clin Nephrol 2010; 74: 39-43.
38. Lahera V, Cachofeiro V, Balfagon G, Rodicio JL. Aldosterone and its blockade: a cardiovascular and renal perspective. Scientific World J 2006; 6: 413-424.
39. Albert MA, Ravenell J, Glynn RJ, Khera A, Halevy N, de Lemos JA. Cardiovascular risk indicators and perceived race/ethnic discrimination in the Dallas Heart Study. Am Heart J 2008; 156: 1103-1109.
40. Lewis TT, Aiello AE, Leurgans S, Kelly J, Barnes LL. Self-reported experiences of everyday discrimination are associated with elevated c-reactive protein levels in older African-American adults. Brain Behav Immun 2010; 24: 438-443.
41. Antonios TF, MacGregor GA. Deleterious effects of salt intake other than effects on blood pressure. Clin Exp Pharmacol Physiol 1995; 22: 180-184.
42. Boero R, Pignataro A, Quarello F. Salt intake and kidney disease. J Nephrol 2002; 15: 225-229. (Pubitemid 34830527)
43. Dworkin LD, Benstein JA, Tolbert E, Feiner HD. Salt restriction inhibits renal growth and stabilizes injury in rats with established renal disease. J Am Soc Nephrol 1996; 7: 437-442. (Pubitemid 26128314)
44. Sen S, Young D. Effect of sodium deprivation on cardiac hypertrophy in spontaneously hypertensive rats: influence of aging. J Mol Cell Cardiol 1991; 23: 695-704.
45. Urabe A, Izumi T, Abe Y, Taniguchi I, Mochizuki S. Effects of eplerenone and salt intake on left ventricular remodeling after myocardial infarction in rats. Hypertens Res 2006; 29: 627-634. (Pubitemid 44430472)
46. Kannel WB, Castelli WP, McNamara PM, McKee PA, Feinleib M. Role of blood pressure in the development of congestive heart failure. The Framingham Study. N Engl J Med 1972; 287: 781-787.
47. Perrino C, Naga Prasad SV, Mao L, Noma T, Yan Z, Kim HS, Smithies O, Rockman HA. Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction. J Clin Invest 2006; 116: 1547-1560.
48. Zhao M, Fajardo GA, Urashima T, Spin JM, Poorfarahani S, Rajagopalan V, Huynh DT, Connolly AJ, Quertermous T, Bernstein D. Cardiac pressure overload hypertrophy is differentially regulated by {beta}-adrenergic receptors. Am J Physiol Heart Circ Physiol 2011; 301: H1461-H1470.
49. Ferreira DN, Katayama IA, Oliveira IB, Rosa KT, Furukawa LN, Coelho MS, Casarini DE, Heimann JC. Salt-induced cardiac hypertrophy and interstitial fibrosis are due to a blood pressure-independent mechanism in wistar rats. J Nutr 2010; 140: 1742-1751.
50. Suematsu N, Ojaimi C, Recchia FA, Wang Z, Skayian Y, Xu X, Zhang S, Kaminski PM, Sun D, Wolin MS, Kaley G, Hintze TH. Potential mechanisms of low-sodium diet-induced cardiac disease: superoxide-No in the heart. Circ Res 2010; 106: 593-600.
51. Yoshida K, Kim-Mitsuyama S, Wake R, Izumiya Y, Izumi Y, Yukimura T, Ueda M, Yoshiyama M, Iwao H. Excess aldosterone under normal salt diet induces cardiac hypertrophy and infiltration via oxidative stress. Hypertens Res 2005; 28: 447-455. (Pubitemid 41007460)
52. Garlie JB, Hamid T, Gu Y, Ismahil MA, Chandrasekar B, Prabhu SD. Tumor necrosis factor receptor 2 signaling limits beta-adrenergic receptor-mediated cardiac hypertrophy in vivo. Basic Res Cardiol 2011; 106: 1193-1205.
53. Flaherty MP, Brown M, Grupp IL, Schultz JE, Murphree SS, Jones WK. eNOS deficient mice develop progressive cardiac hypertrophy with altered cytokine and calcium handling protein expression. Cardiovasc Toxicol 2007; 7: 165-177. (Pubitemid 47575002)
54. Gu JW, Tian N, Shparago M, Tan W, Bailey AP, Manning Jr RD. Renal nf-kappab activation and tnf-alpha upregulation correlate with salt-sensitive hypertension in dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol 2006; 291: R1817-R1824. (Pubitemid 44904151)